3rd Quarter - Amendment

SIDLEY AUSTIN LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 15, 2009 $30,000 Replaced
3rd Quarter - Report Oct 30, 2009 $30,000 Replaced
3rd Quarter - Amendment (this page) Oct 30, 2009 $30,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

WTO enforcement actions on intellectual property; pharmaceutical industry issues pertinent in WTO and FTA negotiations and implementation

LobbyistCovered position, as disclosed
JON P SANTAMAURO New N/A
ANDREW W SHOYER N/A

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); SENATE; Treasury, Dept of

Health Issues HCR

Health care reform, H.R. 3200

LobbyistCovered position, as disclosed
JOHN P FORD New Sr. Counsel, House Energy & Commerce

Contacted: Patent & Trademark Office (PTO); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Treasury, Dept of

Bills named: H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.